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The CO2 laser has been used extensively in dermatological surgery over the past 30 years and is now recognised as the gold
standard for soft tissue vaporization. Considering that the continuous wave CO2 laser delivery system and the newer “superpulsed”
and scanned CO2 systems have progressively changed our practice and patient satisfaction, a long range documentation can
be useful. Our experience has demonstrated that the use of CO2 laser involves a reduced healing time, an infrequent need for
anaesthesia, reduced thermal damage, less bleeding, less inflammation, the possibility of intra-operative histologic and/or cytologic
examination, and easy access to anatomically difficult areas. Immediate side effects have been pain, erythema, edema, typically see
with older methods, using higher power. The percentage of after-treatment keloids and hypertrophic scars observed was very low
(∼1%) especially upon the usage of lower parameters. The recurrence of viral lesions (condylomas and warts) have been not more
frequent than those due to other techniques. Tumor recurrence is minor compared with radiotherapy or surgery. This method is
a valid alternative to surgery and/or diathermocoagulation for microsurgery of soft tissues. Our results are at times not consistent
with those published in the literature, stressing the concept that multicentric studies that harmonization methodology and the
patient selection are vital.
1. Introduction
Laser surgery has become a powerful and indispensable
instrument in dermatology. The first CO2 laser systems,
which used continuous wave delivery systems, were effi-
cient at ablating and also cutting the tissues. The high
incidence of possible scars, however, limited its usage in
the vaporization of thin, superficial layers. The efficacy was
guaranteed, but the uninterrupted energy transfer often
elicited a thermal damage extending in the tissue up to a
depth of approximately 0.5–1mm, carbonizations, frequent
pigmentary modifications, and a slower cicatrization pro-
cess. Technological development has yielded high-energy,
“superpulsed,” and scanned CO2 systems which are now able
to emit shorter pulses with high peaks of power. This in
turn allows laser surgeons to ablate epidermal and dermal
tissue with minimal risk of scarring, results in a precise and
adequate vaporization of superficial skin layers, and limits
thermal damage to surrounding tissues [1, 2].
Initial modifications in the continuous wave laser system
has involved the electronic shuttering of the continuous
beam of light to produce 0.1 to 1 second “pulse” duration at
a consistent power. After these initial changes, “superpulsed”
systems capable of attaining peak powers 2 to 10 times
higher and pulse durations 10 to 100 times shorter than
conventional models were developed [3].
The carbon dioxide (CO2) laser has been used extensively
in dermatological surgery departments and is currently
recognized as the gold standard for vaporization of the
soft tissues [4, 5]. In the following paper, we report our
experience in comparison with data already published in this
field [6–45].
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Figure 1: Acne scars at first (a) and after (b) only two treatments with fractional microablative CO2 laser.
(a) (b)
Figure 2: Rhinophyma at first (a) and after (b) five treatments with CO2 laser.
2. A 30-Year Survey of CO2 Laser Surgery
Given a thirty-year experience in the field of CO2 laser,
we have surveyed a wide range of patients having various
pathologies. In our clinic, 43,000 patients were treated,
18,000 males and 25,000 females. The age range was 20–90
years old, and approximately 300 patients were younger than
20. Common skin disorders such as molluscum contagio-
sum, palmar-plantar warts, and pyogenic granulomas were
seen in our clinic (Figures 1, 2, 3, 4, 5, 6, 7, 8, and 9).
CO2 SmartXide laser (DEKA-M.E.L.A., Calenzano, Italy)
is typically performed with a superpulse mode rather than
a continuous one (except in cases of plantar warts, certain
types of rhynophymas, and giant condylomas): this ensures
that all treated zones are always “levelled” to the desired
thickness. We usually operate with a power range of 0.5–
1W and a frequency of 10Hz but sometimes increase the
frequency to 20Hz and use up to 2W power. The actual
values depend on the type of lesion; for example, with plantar
warts we usually use a 10–15W power in continuous mode
and with rhinophyma we use a 50–100HZ frequency with a
6–10W power (Table 1).
Typically, we use slightly defocalized laser beams; how-
ever, for heating (i.e., seborrheic keratoses) or coagulation
purposes, defocalized treatment is normally used.
An important advantage in the use of this type of laser
is the reduced need for anaesthesia. In our clinical practice,
The Scientific World Journal 3
(a) (b) (c)
Figure 3: N. E. V. I. L. at first (a) and after three (b) and six (c) treatments with CO2 laser.
(a) (b)
Figure 4: Dermatosis papulosa nigra at first (a) and after one (b) treatment with CO2 laser.
we typically do not use anaesthesia with a power lower than
1-2W and a frequency of 10–20Hz. These parameters how-
ever depend upon the site, type, and level of lesions. We limit
the use of anaesthesia since the procedure itself is less painful
for the patient and also because local anaesthesia could cause
edema and hinder the “visual feedback processing” during
treatment. When treating more difficult and sensitive body
areas, such as the eyes, periocular, oral, and anal areas,
genital mucosa, and fingers, local anaesthesia is utilized. In
such select cases, we sometimes suggest the application of
a eutectic mixture of lidocaine 2.5% and prilocaine 2.5% in
an oil-in-water emulsion, especially for small and superficial
lesions. This is applied under occlusion two hours before
treatment (thirty minutes for mucosal lesions) and removed
just before the procedure. After vaporization, the carbonized
residue is removed with gauze soaked in physiologic solution.
In this way, “we can see immediately what we get.”
After treatment, we usually suggest the application of
topical antibiotics on the lesion covered by a traditional
patch, when bald areas, the face, or other photoexposed areas
are involved. We use a hydrocolloid transparent dressing
that is permeable to water vapour but impermeable to
exudate and microorganisms since it has a high absorbency
and can manage the wound exudate and skin secretions.
The transparent dressing facilitates inspection of the wound
without removing it; the healing process can therefore be
monitored closely. The patient can remove the transparent
dressing every day and wash the wound with a cleansing
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(a) (b)
Figure 5: Favre-Racouchot’s disease at first (a) and after (b) one treatment with CO2 laser.
(a) (b)
Figure 6: Facial wrinkles at first (a) and after (b) three treatments with fractional microablative CO2 laser.
(a) (b)
Figure 7: Vulgar warts at first (a) and after one (b) treatment with CO2 laser.
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Figure 8: Xanthelasma at first (a) and after (b) one treatment with CO2 laser.
(a) (b)
Figure 9: Inverted follicular keratosis at first (a) and after (b) one treatment with CO2 laser.
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Figure 10: Water absorption coefficient in the infrared band.
foam and then reapply the dressing, for one to two weeks,
without crust formation, and protect the wound with
sunscreens. The redness disappears within few weeks.
A major criticism regarding laser treatment for com-
mon skin neoplasms (e.g., in the treatment of basal cell
carcinoma (BCC)), lies in the fact that this technique
would not allow the operator to perform an intraoper-
ative histopathologic/cytologic examination, thus limiting
the certainty of its complete removal. In our practice,
however, we have acquired extensive experience in treating
BCCs with CO2 laser associated with intraoperative cyto-
logic/histopathologic examination obtained by scraping the
lesion prior to vaporising with laser through successive layers
of the skin. The aforementioned technique is possible due
to the use of low parameters, so as not to create thermal
tissue damage. A similar procedure could be of interest for
other skin diseases, such as actinic keratosis, squamous cell
carcinoma (selective cases), actinic cheilitis, Bowen’s disease,
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Table 1: Treated lesions.
Benign epidermal tumours
Seborrheic keratoses
Follicular inverse keratoses
Epidermal and sebaceous nevi
35.720
75
5706
Frequency: 10 HZ
Power: 0.5–3W
Benign pilar and sebaceous tumours
Facial Milia
Trichoepitheliomas
Sebaceous adenoma
Small sebaceous cysts
12.230
2.570
8.040
425
Frequency: 10HZ
Power: 0.5–1W
Benign tumours of eccrine glands
Syringomas
1235
Frequency: 10HZ
Power: 0.5–1W
Malign epidermal tumours
Basal Cell carcinoma (Bcc)
Superficial (also extensive)
Nodular (<1 cm diameter)
2505
Frequency: 10 HZ
Power: 0.5–5W
Viral lesions
Warts
Acuminate condylomas
Squamous papillomas
Oral cavity
12.235
8.503
58
Frequency: 10 HZ
Power: 0.5–3W
For Plantar Warts:
Continuous Mode
(Power 10–15W)
Dermal hypertrophy
Pendulous fibromas
Skin neurofibromas
45.023
150
Frequency: 10HZ
Power: 0.5–1W
Scars
Acne, surgical, traumatic, post-chickenpox
7.502
Frequency: 10HZ
Power: 0.5–1W
Fatty accumulation
Xanthelasmas
7.234
Frequency: 10 HZ
Power: 0.5–1W
Facial dermatosis
Rhynophymas (glandular type)
Otophyma
506
35
Frequency: 50–100W
Power: 6-7W
(Superpulse or
Continuous Mode)
Precancerous
Actinic keratoses
Actinic cheilitis
Leukoplakia
25.213
807
503
Frequency: 10 HZ
Power: 0.5−3W
Others
Favre-Racouchot’s disease
Pringle-Bourneville’s disease
Chondrodermatites nodularis helicis
124
304
432
Frequency: 10 HZ
Power: 0.5–1W
and leukoplakia, where intraoperative cytologic examination
could be beneficial, as proposed by our laser team [46].
Another important novelty in the removal of wrinkles
and damage caused by skin photoaging or other skin
imperfections, such as acne scars, is the use of a modified
device and associated software with a novel handpiece: the
“fractional microablative resurfacing with CO2 laser” [47–
58]. The introduction of scanner systems demonstrates a
substantial progress in the field of skin resurfacing respect
to CO2 laser demonstrated by free hand movement on
the handpiece. Nevertheless the purpose of the traditional
scanner with CO2 sources in resurfacing was connected
with a higher occurrence of side effects due to intense
heating and high thermal damage such as pain, long-lasting
erythema, and pigmentary disorders [59]. With the advent
of newer special scanning systems, the fractional CO2 laser
emission takes place by means of dots (DOT), generat-
ing microareas of ablative and thermal damage (MTZ =
microthermal zones) alternated with healthy tissue. In the
treated microareas, a controlled heat release produces imme-
diate tissue shrinkage and stimulates neocollagenogenesis.
The areas of healthy tissue between the treated areas ensure
rapid tissue repair and a drastic reduction in recovery
time and posttreatment erythema [60–62]. This exclusive
emission system allows us to control tissue damage while
simultaneously maximizing efficacy. Thus, the fractional
laser can be considered an effective alternative to topical
treatments such as (Tretinoin, α-hydroxyacids), chemical
peelings, botulinum toxin, and filler injections [63–66].
The settings usually implemented include a power of 10–
30W, a DOT spacing of 500–1000 μm, stack 1–3, and dwell
time of 500–2000 μs. We usually prefer to work in a range of
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10–20W because it allows us to reach a lower intensity and
duration of side effects. Anaesthetics are not needed in the
procedure; rather external cryogen is utilized.
We must also consider that laser peels can activate a her-
pes virus infection and possibly other dormant pathogens.
In most cases, a patient is given an oral antiviral drug
or sometimes antibiotics in the case of bacterial infection
before and after the laser surgery procedure. There is always
a risk of postinflammatory pigmentary changes following
any type of inflammatory process in the skin. Fractional
laser treatments are not an exception—the risk is most
common in patients with a history of postinflammatory
hyperpigmentation (PIH) ormelasma. PIH is more common
in patients of darker skin types (IV–VI). A precautionary
pre-post treatment with a lightening cream for a few weeks
followed by a strict sun-protection regimen is advisable for
all these individuals.
A new parameter is the stack setting. This function allows
the physician to set the number of pulses to deliver on the
same DOT of the tissue, before moving to the next DOT
according to the scanning modality selected. For example,
when choosing stack 3, the system automatically triples the
number of pulses on the same DOT; thus the thermal and
ablative effect on the tissue during a single passage are tripled,
without a considerable change in the time required. This
stack function multiplies the effect on the skin and is a much
better approach than repeating a laser scan on the tissue three
times (three “passages,” pushing three times the pedal of the
laser device).
While using the latter traditional method, it is possible
that the tissue can move during the session. In the next
passage, the laser may not uniformly place itself above all the
DOTs. The stack function, however, has a further advantage
given by the quickness of the laser scanning [67–70]. In this
manner, the ablation depth and stimulation of the tissues
are precisely controlled, adapting the treatment to the area
in question according to the specific skin condition and
the patient’s needs. This function allows deeper penetration
since the laser treatment can be repeated with the same
parameters over the dots in the same scanner passage,
making possible a wide range of effects and further increasing
its flexibility [70, 71].
3. Side Effects Experienced inOur Laser Practice
Laser treatment comes with the possibility of side effects.
In our experience, immediate side effects consist of pain,
erythema, and edema, which are found mainly with old
methods, using higher powers, which result in long recovery
times of weeks or even months. With the new “superpulsed”
and scanned CO2 systems, which are associated with the
use of lower parameters, we have been able to limit edema
and erythema possibly within hours or days after treatment.
In some cases, episodes of hypochromia and hyperchromia
have taken place, which occur most often when treatments
are carried out during the summer rather than winter.
However, these have become transient with the use of newer
instruments.
The percentage of after-treatment keloids and hyper-
trophic scars has been very low (∼1%) above all when
using lower parameters. The recurrence of viral lesions
(condylomas and warts) have not been more frequent than
those due to other techniques, and recurrence of the tumors
has been minor compared with radiotherapy or surgery.
Three patients developed retracting scars of the inner part of
the upper eyelid after the treatment of xanthelasmas, while
alopecic patches have developed in other five patients after
the treatment of scalp lesions. We have seen ten cases of
hypochromia and atrophy when CO2 laser was also used in
the treatment of vascular lesions, such as venous gaps of the
lips.
In regards to the use of fractional CO2 laser, a more
prolonged erythema has resulted in dyschromia in our
patients. Herpes virus reactivation or other infections did
occur, even if our patients were treated with systemic
antiviral or antibiotics before and after the treatment.
However, in addition to a correct setting of parameters
by the dermatologist, equally important is the diligent
medication after surgery that we recommend to our patients
in order to avoid the occurrence of side effects that result in
a more difficult and prolonged patient management.
4. Discussion
The basis of laser application is the conversion of laser energy
into heat [72, 73]. The interaction between the electro-
magnetic radiation emitted by a laser source and biological
tissues is governed by physical processes, which regulate the
exchange of energy between the wave and the substrate, and
by the biological response of the targeted tissue. Depending
on the temperature reached in a specific area, the thermal
energy produced is capable of coagulating, vaporizing,
or ablating. With a sufficiently high fluence (above the
minimum ablation threshold), the heat is mainly used for
ablating or vaporising the targeted tissue, before beginning
to spread more slowly towards the surrounding areas.
Thermal relaxation time (TRT) refers to the time it takes
for the irradiated “target” tissue to lose 50% of the incident
heat, without heat conduction to the surrounding tissues.
The correct use of the surgical lasers takes into consideration
that less thermal damage is obtained with higher power and
laser pulses with shorter amplitudes than the TRT of the
selected target. This is the theory behind selective photother-
molysis, namely, selective tissue heating by preferential light
absorption and heat production in the targeted tissue with
appropriate wavelengths and pulse durations. Theoretical
arguments suggest that using these principles combined with
the proper pulse parameters would confine thermal damage
and result in decreased scarring rates, improved clinical
responses, and faster healing times [73–77].
The CO2 laser works at a wavelength of 10600 nm, in the
far-infrared spectrum where chromophore absorption of the
intracellular and extracellular water molecules is prevalent.
This high water absorption is an important factor that
explains the reduced penetration depth of CO2 lasers,
such as the Er: YAG laser whose penetration is much less
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than CO2 laser [78–82] (Figure 10). Water is the principal
component of the skin (approximately 77% of its volume)
and consequently plays an essential role in the laser-tissue
interaction, above all in dermatology. CO2 laser is a type
of “no-contact surgery” belonging to the group of lasers
in the category “WYSIWYG” (what you see is what you
get—the operator can directly estimate the level reached
during treatment with a “step-by-step” procedure). In fact,
these laser systems enable precise, efficacious, and targeted
thermal action on the lesions treated while at the same time
protecting the adjacent areas thus guaranteeing optimal re-
epithelialization. This makes it suitable for surgical proce-
dures since the limited inflammatory response is conducive
to better healing. The extreme precision of the application
means that the epidermis alone can be vaporised, or the
thermal effect can be extended even deeper into the papillary
or reticular derma. Thanks to “colour indicators,” a step-by-
step visual assessment of the level reached and an accurate
calculation of the clinical “end-point” phase are possible.
Clinical and histologic studies have demonstrated the effects
of thermal damage in relation to the skin layer reached and
the level of energy delivered. When vaporization is confined
to the epidermis, an opalescent aspect is obtained, with
the formation of microbubbles accompanied by a typical
“crackling sound.” After removing the carbon residues with
a physiologic solution, the papillary derma will appear and
emerges as a flat, smooth, pink surface. Further vaporization
reveals a hardened yellowish tissue similar to “chamois skin,”
typical of the superficial derma. The next step, involving
vaporisation of the reticular derma, reveals large collagen
fibre fascias that in macroscopic terms look like “waterlogged
cotton threads [2, 3, 73, 74].’’
The CO2 laser produces the most dramatic improve-
ments in the clinical and histologic appearance of photodam-
aged or scarred skin. Epidermal ablation occurs after 1 pass of
the CO2 laser at standard treatment parameters (vaporizing
tissue to a depth of 20–60 μm), but collagen shrinkage and
remodelling—the 2 factors most likely responsible for the
long-term clinical improvements seen after resurfacing—
require 1 to 2 additional passes. When dermal temperatures
exceed 55◦C to 62◦C, there is disruption of interpeptide
bonds leading to conformational changes within collagen’s
triple helical structure that shrink the moiety to one-third
its normal length. The mechanisms of long-term collagen
remodelling and neocollagenesis after resurfacing are not
fully known. However, it is believed that these effects
result from thermal desiccation with concomitant collagen
shrinkage [79, 80].
The advantages of CO2 laser include a reduced healing
time, an infrequent need for anaesthesia, reduced thermal
damage, less bleeding, less inflammation, and minimal
undesirable side effects (unaesthetic scarring and dyschromic
effects). These benefits must be considered in comparison
with other available surgical techniques such as diathermo-
coagulation and traditional surgery which on the contrary
necessitate frequent anaesthetics, a longer recovery period,
a slower cicatrisation, and a high incidence of hypertrophic
scars and keloids. Another relevant limitation of these two
surgical treatments is its limited usage in many anatomically
difficult areas such as the internal corner of the eyes, the ears,
the alae of the nose, and the genitals, areas characterized
by a high incidence of cutaneous damage upon using these
techniques. The laser CO2 technique is preferred in patients
with several or wide lesions, those with a pacemaker, or for
patients who cannot be subjected to anaesthetics [75–78].
5. Conclusion
In this paper, we have stressed the efficacy and versatility
of the “no-contact surgery” performed by the superpulsed
CO2 laser and have witnessed that that this method is a
valid alternative to surgery and/or diathermocoagulation for
microsurgery of the soft tissues. The main benefit of the
superpulsed system is the precise and adequate vaporization,
its targeted thermal action on the lesions with minimal
thermal damage of the adjacent areas which enables step-by-
step visual assessment of the level reached, and an accurate
calculation of the clinical “end point” by the operator,
according to the principle of the “what you see is what you
get.” The operator can decide whether only to vaporize the
epidermis or to extend thermal damage even into the deeper
derma.
The technique guarantees the possibility of laser appli-
cation without anaesthesia because the procedure itself is
less painful and also because local anaesthesia could cause
swelling and hinder the “visual feedback processing” in
most cases. In our clinical practice, therefore, we do not
use anaesthesia with powers lower than 1-2W and in
select cases suggest the application of a topical anaesthesia
before treatment. This technique has few postoperative
complications, and with appropriate patient compliance
involving the application of topical antibiotics without scab
removal (as this delays the healing process), the CO2 laser
ensures rapid healing within one or two weeks. Finally,
the possibility of intraoperative histologic and/or cytologic
examination is another important advantage. The advent
of fractional photothermolysis, initially introduced for non-
ablative systems, has enabled the development of a new
method that meets these demands perfectly, namely, the
fractional microablative resurfacing with CO2 laser for
treating wrinkles and damage caused by skin chronoaging,
photoaging, or other environmental damages.
These findings in essence make the CO2 laser the most
frequently used in our dermatologic clinical practice, espe-
cially for the treatment of aesthetic diseases. The treatment
of wrinkles and scars using fractional lasers by contrast
produces results that could create disappointing results in the
short and long term. It must also be mentioned that the data
obtained in our department are sometimes not consistent
with those published in the literature, stressing the concept
that multicentric studies oriented to the harmonization of
the methods and patient selection are mandatory.
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